Pharmaceuticals in Pregnancy Research
During pregnancy, most women are advised to avoid pharmaceuticals. However, when it becomes unavoidable, with little research in the field, how can women and their physicians know what's safe and when in the pregnancy it's safe? The University of Rochester is working to find the answers. With an emphasis on the placenta and how particles such as pharmaceuticals, metals, vitamins and nanoparticles cross this organ, our researchers are discovering how pharmaceuticals affect the mother and the fetus during pregnancy.
PEDECS
The Perinatal Environmental and Drug Consultation Service (New York Teratogen Information Service) in the Department of Obstetrics and Gynecology at the University of Rochester Medical Center was begun in 1987 and provides expertise concerning exposures during pregnancy or before pregnancy to environmental, occupational and therapeutic exposures to the women and/or family. Dr. Miller, director of the program, has recently co-edited a volume on these subjects entitled, "Drugs During Pregnancy and Lactation - Treatment Options and Risk Assessment". Dr. Miller provides these services to health care providers and families by telephone or by appointment. Please call 585 275 3638.
Interested Faculty:
Richard K. Miller, Ph.D.,
Christopher J Stodgell, Ph.D.
Additional Resources

Email this page